Tschöpe, Carsten

A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology

Cardiovascular Function and Risk FactorsCardiac Fibrosis and Remodeling

Cited by 3,564

Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy

Templin, C., Ghadri, J. R., Diekmann, J., Napp, L. C., Bataiosu, D. R., Jaguszewski, M., Cammann, V. L., Sarcon, A., Geyer, V., Neumann, C. A., et al. (2015) · New England Journal of Medicine

Takotsubo Cardiomyopathy and Associated PhenomenaPsychosomatic Disorders and Their Treatments

Cited by 2,595

Myocarditis and inflammatory cardiomyopathy: current evidence and future directions

Tschöpe, C., Ammirati, E., Bozkurt, B., Caforio, A. L. P., Cooper, L. T., Felix, S. B., Hare, J. M., Heidecker, B., Heymans, S., Hübner, N., et al. (2021) · Nature Reviews Cardiology

Viral Infections and Immunology ResearchCardiac Fibrosis and Remodeling

Cited by 1,217

Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document

Ammirati, E., Frigerio, M., Adler, E. D., Basso, C., Birnie, D. H., Brambatti, M., Friedrich, M. G., Klingel, K., Lehtonen, J., Moslehi, J. J., et al. (2020) · Circulation: Heart Failure

Viral Infections and Immunology ResearchPericarditis and Cardiac Tamponade

Cited by 811

Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology

Seferović, P. M., Petrie, M. C., Filippatos, G. S., Anker, S. D., Rosano, G., Bauersachs, J., Paulus, W. J., Komajda, M., Cosentino, F., de Boer, R. A., et al. (2018) · European Journal of Heart Failure

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 708

Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction

Westermann, D., Lindner, D., Kasner, M., Zietsch, C., Savvatis, K., Escher, F., von Schlippenbach, J., Skurk, C., Steendijk, P., Riad, A., et al. (2011) · Circulation Heart Failure

Cardiac Fibrosis and RemodelingCardiovascular Function and Risk Factors

Cited by 644

Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation

Kolijn, D., Pabel, S., Tian, Y., Lódi, M., Herwig, M., Carrizzo, A., Zhazykbayeva, S., Kovács, Á., Fülöp, G. Á., Falcão-Pires, I., et al. (2021) · Cardiovascular Research

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 323

SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes

Bojkova, D., Wagner, J. U. G., Shumliakivska, M., Aslan, G. S., Saleem, U., Hansen, A., Luxán, G., Günther, S., Pham, M. D., Krishnan, J., et al. (2020) · Cardiovascular Research

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 257

Empagliflozin directly improves diastolic function in human heart failure

Pabel, S., Wagner, S., Bollenberg, H., Bengel, P., Kovács, Á., Schach, C., Tirilomis, P., Mustroph, J., Renner, A., Gummert, J., et al. (2018) · European Journal of Heart Failure

Cardiovascular Function and Risk FactorsHeart Failure Treatment and Management

Cited by 224

Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy

Seferović, P. M., Tsutsui, H., McNamara, D. M., Ristić, A. D., Basso, C., Bozkurt, B., Cooper, L. T., Filippatos, G., Ide, T., Inomata, T., et al. (2021) · European Journal of Heart Failure

Viral Infections and Immunology ResearchTransplantation: Methods and Outcomes

Cited by 219

Myocarditis Following COVID-19 Vaccine: Incidence, Presentation, Diagnosis, Pathophysiology, Therapy, and Outcomes Put Into Perspective. A Clinical Consensus Document Supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases

Heidecker, B., Dagan, N., Balicer, R., Eriksson, U., Rosano, G., Coats, A., Tschöpe, C., Kelle, S., Poland, G. A., Frustaci, A., et al. (2022) · European Journal of Heart Failure

Viral Infections and Immunology ResearchSARS-CoV-2 and COVID-19 Research

Cited by 159

Cardiac Deletion of the Coxsackievirus-Adenovirus Receptor Abolishes Coxsackievirus B3 Infection and Prevents Myocarditis In Vivo

Shi, Y., Chen, C., Lisewski, U., Wrackmeyer, U., Radke, M., Westermann, D., Sauter, M., Tschöpe, C., Poller, W., Klingel, K., et al. (2009) · Journal of the American College of Cardiology

Viral Infections and Immunology ResearchCardiac Fibrosis and Remodeling

Cited by 112

Blocking the IL-1β signalling pathway prevents chronic viral myocarditis and cardiac remodeling

Kraft, L., Erdenesukh, T., Sauter, M., Tschöpe, C., & Klingel, K. (2019) · Basic Research in Cardiology

Viral Infections and Immunology ResearchCardiac Fibrosis and Remodeling

Cited by 107

Elevated Sera sST2 Is Associated With Heart Failure in Men ≤50 Years Old With Myocarditis

Coronado, M. J., Bruno, K. A., Blauwet, L. A., Tschöpe, C., Cunningham, M. W., Pankuweit, S., van Linthout, S., Jeon, E., McNamara, D. M., Krejčí, J., et al. (2019) · Journal of the American Heart Association

Viral Infections and Immunology ResearchCardiac Fibrosis and Remodeling

Cited by 99

NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis

Tschöpe, C., Müller, I., Xia, Y., Savvatis, K., Pappritz, K., Pinkert, S., Lassner, D., Heimesaat, M. M., Spillmann, F., Miteva, K., et al. (2017) · Circulation: Heart Failure

Viral Infections and Immunology ResearchCardiac Fibrosis and Remodeling

Cited by 88

IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination

Thurner, L., Kessel, C., Fadle, N., Regitz, E., Seidel, F., Kindermann, I., Lohse, S., Kos, I., Tschöpe, C., Kheiroddin, P., et al. (2022) · New England Journal of Medicine

Viral Infections and Immunology ResearchSARS-CoV-2 and COVID-19 Research

Cited by 83

Colchicine Prevents Disease Progression in Viral Myocarditis Via Modulating the NLRP3 Inflammasome in the Cardiosplenic Axis

Pappritz, K., Lin, J., El-Shafeey, M., Fechner, H., Kühl, U., Alogna, A., Spillmann, F., Elsanhoury, A., Schulz, R., Tschöpe, C., et al. (2022) · ESC Heart Failure

Viral Infections and Immunology ResearchInflammasome and immune disorders

Cited by 74

Epicardial Fat Expansion in Diabetic and Obese Patients with Heart Failure and Preserved Ejection Fraction—A Specific HFpEF Phenotype

Elsanhoury, A., Nelki, V., Kelle, S., Van Linthout, S., & Tschöpe, C. (2021) · Frontiers in Cardiovascular Medicine

Cardiovascular Disease and AdiposityHeart Failure Treatment and Management

Cited by 51

Transgenic overexpression of adenine nucleotide translocase 1 protects ischemic hearts against oxidative stress

Klumpe, I., Savvatis, K., Westermann, D., Tschöpe, C., Rauch, U., Landmesser, U., Schultheiss, H.-P., & Dörner, A. (2016) · Journal of Molecular Medicine

Cardiac Ischemia and ReperfusionMitochondrial Function and Pathology

Cited by 35

SARS-CoV-2 infection causes prolonged cardiomyocyte swelling and inhibition of HIF1α translocation in an animal model COVID-19

Daems, M., Liesenborghs, L., Boudewijns, R., Simmonds, S. J., Kraisin, S., Van Wauwe, J., Cuijpers, I., Raman, J., Geuens, N., Buyten, T. V., et al. (2022) · Frontiers in Cardiovascular Medicine

COVID-19 Clinical Research StudiesViral Infections and Immunology Research

Cited by 8